Controversially, at later stages, COVID-19 patients present an impaired immune response due to exhausted phenotype and lower effector T cells, CD8+ T lymphocytes, and NK cells, culminating in antiviral immunity loss. This evidence concerns the gene CD8A and COVID-19.